These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17268103)

  • 1. Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones.
    Huang HS; Chen IB; Huang KF; Lu WC; Shieh FY; Huang YY; Huang FC; Lin JJ
    Chem Pharm Bull (Tokyo); 2007 Feb; 55(2):284-92. PubMed ID: 17268103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
    Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
    Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of telomerase inhibitory, hTERT repressing, and anti-proliferation activities of symmetrical 1,8-disubstituted amidoanthraquinones.
    Lee CC; Huang KF; Chang DM; Hsu JJ; Huang FC; Shih KN; Chen CL; Chen TC; Chen RH; Lin JJ; Huang HS
    Eur J Med Chem; 2012 Apr; 50():102-12. PubMed ID: 22357112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones.
    Huang HS; Chou CL; Guo CL; Yuan CL; Lu YC; Shieh FY; Lin JJ
    Bioorg Med Chem; 2005 Mar; 13(5):1435-44. PubMed ID: 15698759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone.
    Huang HS; Chiou JF; Fong Y; Hou CC; Lu YC; Wang JY; Shih JW; Pan YR; Lin JJ
    J Med Chem; 2003 Jul; 46(15):3300-7. PubMed ID: 12852760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives.
    Lee CC; Huang KF; Lin PY; Huang FC; Chen CL; Chen TC; Guh JH; Lin JJ; Huang HS
    Eur J Med Chem; 2012 Jan; 47(1):323-36. PubMed ID: 22100139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase.
    Perry PJ; Gowan SM; Reszka AP; Polucci P; Jenkins TC; Kelland LR; Neidle S
    J Med Chem; 1998 Aug; 41(17):3253-60. PubMed ID: 9703471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, telomerase evaluation and anti-proliferative studies on various series of diaminoanthraquinone-linked aminoacyl residue derivatives.
    Huang FC; Huang KF; Chen RH; Wu JE; Chen TC; Chen CL; Lee CC; Chen JY; Lin JJ; Huang HS
    Arch Pharm (Weinheim); 2012 Feb; 345(2):101-11. PubMed ID: 21956661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[1,2-d]imidazole-6,11-dione homologues.
    Huang HS; Chen TC; Chen RH; Huang KF; Huang FC; Jhan JR; Chen CL; Lee CC; Lo Y; Lin JJ
    Bioorg Med Chem; 2009 Nov; 17(21):7418-28. PubMed ID: 19804981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoacyl-anthraquinone conjugates as telomerase inhibitors: synthesis, biophysical and biological evaluation.
    Zagotto G; Sissi C; Lucatello L; Pivetta C; Cadamuro SA; Fox KR; Neidle S; Palumbo M
    J Med Chem; 2008 Sep; 51(18):5566-74. PubMed ID: 18754611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
    Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS
    Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents.
    Chen TC; Yu DS; Huang KF; Fu YC; Lee CC; Chen CL; Huang FC; Hsieh HH; Lin JJ; Huang HS
    Eur J Med Chem; 2013 Nov; 69():278-93. PubMed ID: 24051300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
    Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
    J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives.
    Huang HS; Chiu HF; Lee AL; Guo CL; Yuan CL
    Bioorg Med Chem; 2004 Dec; 12(23):6163-70. PubMed ID: 15519160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships.
    Read MA; Wood AA; Harrison JR; Gowan SM; Kelland LR; Dosanjh HS; Neidle S
    J Med Chem; 1999 Nov; 42(22):4538-46. PubMed ID: 10579817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase.
    Perry PJ; Read MA; Davies RT; Gowan SM; Reszka AP; Wood AA; Kelland LR; Neidle S
    J Med Chem; 1999 Jul; 42(14):2679-84. PubMed ID: 10411488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives.
    Zagotto G; Sissi C; Moro S; Dal Ben D; Parkinson GN; Fox KR; Neidle S; Palumbo M
    Bioorg Med Chem; 2008 Jan; 16(1):354-61. PubMed ID: 17936629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modelling and cytotoxicity of substituted anthraquinones as inhibitors of human telomerase.
    Cairns D; Michalitsi E; Jenkins TC; Mackay SP
    Bioorg Med Chem; 2002 Mar; 10(3):803-7. PubMed ID: 11814869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of small molecule inhibitors of telomerase activity through transcriptional regulation of hTERT and calcium induction pathway in human lung adenocarcinoma A549 cells.
    Rao YK; Kao TY; Wu MF; Ko JL; Tzeng YM
    Bioorg Med Chem; 2010 Oct; 18(19):6987-94. PubMed ID: 20813535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.